소화성궤양 치료제 시장 규모, 점유율, 성장 분석 : 약물 유형별, 궤양 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Peptic Ulcer Drugs Market Size, Share, Growth Analysis, By Drug Type (Proton Pump Inhibitors, H2 Antagonists), By Ulcer Type (Gastric Ulcer, Duodenal Ulcer), By End User, By Region - Industry Forecast 2025-2032
상품코드:1622432
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
소화성궤양 치료제 시장 규모는 2023년 47억 6,000만 달러로 예측 기간(2025-2032년) 동안 3.50%의 CAGR로 2024년 49억 3,000만 달러에서 2032년 64억 9,000만 달러로 성장할 것으로 예상됩니다.
세계 소화성궤양 치료제 시장은 다양한 촉진요인에 힘입어 상승세를 보이고 있습니다. 소화성궤양 질환은 전 세계적으로 수백만 명이 앓고 있으며, 이 위장 질환의 유병률 증가, 고령화 인구의 증가, 흡연 및 음주와 같은 건강에 해로운 생활습관의 급증으로 인해 시장이 성장하고 있습니다. 의료 기술의 발전과 혁신적인 제제의 도입은 시장 성장을 더욱 촉진하고 있습니다. 그러나 제네릭 의약품의 가용성과 대체 치료법의 부상과 같은 도전과제도 존재합니다. 그러나 조기 진단과 효과적인 치료의 중요성에 대한 인식이 높아짐에 따라 이러한 도전에도 불구하고 지속적인 성장을 보장하고 시장을 발전시킬 것으로 예상됩니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
소화성궤양 치료제 시장 규모 : 약물 유형별
시장 개요
양성자 펌프 억제제
H2 길항제
항생제
기타
소화성궤양 치료제 시장 규모 : 궤양 유형별
시장 개요
위궤양
십이지장궤양
식도궤양
소화성궤양 치료제 시장 규모 : 최종사용자별
시장 개요
병원
소매 약국
온라인 약국
소화성궤양 치료제 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2022-2024)
주요 기업 개요
AstraZeneca plc.(United Kingdom)
Pfizer Inc.(United States)
Novartis AG(Switzerland)
Takeda Pharmaceutical Company Limited(Japan)
GlaxoSmithKline plc.(United Kingdom)
Sanofi S.A.(France)
Johnson & Johnson(United States)
Merck & Co., Inc.(United States)
Bayer AG(Germany)
AbbVie Inc.(United States)
Eli Lilly and Company(United States)
Daiichi Sankyo Company, Limited(Japan)
Bristol-Myers Squibb Company(United States)
Mylan N.V.(Netherlands)
Teva Pharmaceutical Industries Ltd.(Israel)
Sun Pharmaceutical Industries Ltd.(India)
Dr. Reddy's Laboratories Ltd.(India)
Cipla Ltd.(India)
Lupin Ltd.(India)
Zydus Cadila(India)
결론과 추천사항
ksm
영문 목차
영문목차
Peptic Ulcer Drugs Market size was valued at USD 4.76 Billion in 2023 and is poised to grow from USD 4.93 Billion in 2024 to USD 6.49 Billion by 2032, growing at a CAGR of 3.50% during the forecast period (2025-2032).
The global peptic ulcer drugs market is on an upward trajectory, fueled by various driving factors. With millions affected by peptic ulcer disease globally, the market is bolstered by the increasing prevalence of this gastrointestinal disorder, an expanding aging population, and a surge in unhealthy lifestyle choices like smoking and alcohol use. Technological advancements in medicine and the introduction of innovative drug formulations further enhance market growth. However, challenges exist, including the availability of generic drugs and the rise of alternative treatment options. Nonetheless, heightened awareness around the significance of early diagnosis and effective treatment is anticipated to propel the market forward, ensuring continued growth in the face of these challenges.
Top-down and bottom-up approaches were used to estimate and validate the size of the Peptic Ulcer Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Peptic Ulcer Drugs Market Segmental Analysis
Global Peptic Ulcer Drugs Market is segmented by drug type, ulcer type, end user and region. Based on drug type, the market is segmented into proton pump inhibitors, H2 antagonists, antibiotics and others. Based on ulcer type, the market is segmented into gastric ulcer, duodenal ulcer and esophageal ulcer. Based on end user, the market is segmented into hospitals, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Peptic Ulcer Drugs Market
The global peptic ulcer drugs market is significantly driven by the rising prevalence of peptic ulcers across the globe. This common gastrointestinal condition impacts millions, creating a heightened demand for effective treatment alternatives. Contributing factors such as unhealthy lifestyles, increased stress levels, and the regular use of non-steroidal anti-inflammatory drugs (NSAIDs) are fueling the surge in peptic ulcer cases. As a result, there is a continued push for innovative and effective medications, fostering overall growth in the market. This increasing incidence emphasizes the urgent need for solutions, making the peptic ulcer drugs market an area of considerable focus and expansion.
Restraints in the Peptic Ulcer Drugs Market
The global peptic ulcer drugs market faces restraint due to the presence of various alternative treatment options. Beyond conventional pharmaceutical interventions, patients often have access to non-pharmacological methods, such as lifestyle alterations, dietary adjustments, and natural remedies, which are perceived as effective alternatives for managing peptic ulcers. This preference for non-drug approaches can significantly diminish the demand for traditional medications. Additionally, concerns regarding the potential side effects and long-term risks associated with the use of peptic ulcer drugs may further deter patients and healthcare providers, thereby affecting overall market dynamics and growth potential.
Market Trends of the Peptic Ulcer Drugs Market
A prominent market trend in the global peptic ulcer drugs sector is the rising preference for proton pump inhibitors (PPIs) as the primary treatment choice. This shift is fueled by the efficacy and safety of PPIs, which outperform other medication classes in reducing stomach acid production and providing lasting relief from ulcer symptoms. Enhanced drug formulations have further increased the bioavailability and compliance of PPIs in patients, making them more appealing. Such factors are contributing to a robust demand for these medications, positioning PPIs as a cornerstone in peptic ulcer therapies and fostering growth within the overall market landscape.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Peptic Ulcer Drugs Market Size by Drug Type & CAGR (2025-2032)
Market Overview
Proton Pump Inhibitors
H2 Antagonists
Antibiotics
Others
Global Peptic Ulcer Drugs Market Size by Ulcer Type & CAGR (2025-2032)
Market Overview
Gastric Ulcer
Duodenal Ulcer
Esophageal Ulcer
Global Peptic Ulcer Drugs Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Retail Pharmacies
Online Pharmacies
Global Peptic Ulcer Drugs Market Size & CAGR (2025-2032)
North America (Drug Type, Ulcer Type, End User)
US
Canada
Europe (Drug Type, Ulcer Type, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Drug Type, Ulcer Type, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Drug Type, Ulcer Type, End User)
Brazil
Rest of Latin America
Middle East & Africa (Drug Type, Ulcer Type, End User)
